These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17363047)

  • 1. Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Selken J; Nichols DE
    Pharmacol Biochem Behav; 2007 Apr; 86(4):622-30. PubMed ID: 17363047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J; Docherty JR
    Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
    Ball KT; Budreau D; Rebec GV
    Brain Res; 2003 Dec; 994(2):203-15. PubMed ID: 14642646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
    Fantegrossi WE; Kiessel CL; Leach PT; Van Martin C; Karabenick RL; Chen X; Ohizumi Y; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2004 May; 173(3-4):270-7. PubMed ID: 14740148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection.
    Blanc G; Trovero F; Vezina P; Hervé D; Godeheu AM; Glowinski J; Tassin JP
    Eur J Neurosci; 1994 Mar; 6(3):293-8. PubMed ID: 7912614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
    Sprague JE; Brutcher RE; Mills EM; Caden D; Rusyniak DE
    Br J Pharmacol; 2004 Jun; 142(4):667-70. PubMed ID: 15159279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical alpha 1-adrenergic regulation of acute and sensitized morphine locomotor effects.
    Drouin C; Blanc G; Trovero F; Glowinski J; Tassin JP
    Neuroreport; 2001 Nov; 12(16):3483-6. PubMed ID: 11733696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
    van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
    Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
    Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
    Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT4 receptors in the nucleus accumbens are specifically involved in the appetite suppressant and not locomotor stimulant effects of MDMA ('ecstasy').
    Francis HM; Kraushaar NJ; Hunt LR; Cornish JL
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):355-63. PubMed ID: 20740276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG; Yamamoto BK
    J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity.
    Atkins K; Burks T; Swann AC; Dafny N
    Brain Res; 2009 Dec; 1302():175-82. PubMed ID: 19769950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
    Vanattou-Saïfoudine N; McNamara R; Harkin A
    Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW; Rempel N; Peng RY; Geyer MA
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.